Episode
Episode 494: Duration of EVP in Multiple Urothelial Cancer Settings / Paper of the Month PPARG Inverse Agonist
- Podcast
- The Uromigos
- Published
- Apr 27, 2026
- Duration seconds
- 2405
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-494-duration-of-evp-in-multiple-urothelial-cancer-settings-paper-of-the-month-pparg-inverse-agonist/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-uromigos-1214845/episode-494-duration-of-evp-in-multiple-urothelial-cancer-settings-paper-of-the-month-pparg-inverse-agonist.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Matt Galsky joins the show to talk about duration of EVP in multiple bladder cancer settings. He also talks about his recent Nature Medicine manuscript on the PPARG inverse agonist in advanced bladder cancer.